THE Gujarat-based Envee Drugs Pvt Ltd (EDPL), a company engaged in development, manufacturing and supply of quality Active Pharmaceutical Ingredients (APIs), intermediates, formulations and cosmetics, is planning to start a new R&D unit for developing new products according to its Managing Director.
"We already have a state of the art R & D laboratory focusing on production optimization and scale up, stability studies and R & D on new molecules in select therapeutical spectrum and current ones," he said and added that Envee is looking forward to long-term growth through continuously establishing itself in newer markets.
"We work hard for our customers.Envee Drugs is an innovation-driven company, keen on providing quality API products to customers in the most cost-effective manner" he said.
The company is keen on going global with pharma regulatory clearances from various countries. Having received several regulatory clearances worldwide, in tune with its core competencies and beliefs, it aims at establishing its own networks in countries of operation for greater efficiency in coverage, establishing brands and quick market response.
The company is already heading a steady growth of its export activities to more than 10 countries. Currently, the company is planning to expand its presence throughout the world with the support of enhanced marketing systems of international sales and promotional activities,he added.
The company maintains a strong hold on the domestic market and a major share of its exports cater to a number of leading buyers all over the world who vouch for the quality of products and services.
It pursues a steady growth of its exporting activities and expanding its presence throughout the world with the support of enhanced marketing systems for international sales & promotional activities.
The company, established in 1998 as the part of Envee group of companies is working with a vision to build a strong and independent pharmaceutical company to provide quality bulk drugs for the global pharma market.
At present, the company has evolved into a leading pharmaceutical company with class expertise in development, manufacturing and supply of world class quality APIs at an excellent value in full compliance with standard established by various regulatory agencies, he commented. The company has its expertise in handling a range of products in macrolides and steroids.